![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Molina Healthcare Inc | TG:MHG | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-4.60 | -1.75% | 258.90 | 256.30 | 257.50 | 264.60 | 258.00 | 262.80 | 471 | 16:48:07 |
RNS Number:4502P Merchant House Group PLC 05 September 2003 FOR IMMEDIATE RELEASE 5 SEPTEMBER 2003 Merchant House Group Plc ('Merchant House' or the 'Company') Circular re change of strategy In accordance with the AIM rules, Merchant House has today despatched to shareholders in the Company a circular dated 5 September 2003 which explains the background to the board's decision to seek approval of certain proposals ('Circular'), the purpose of which is to enable the Company to implement its proposed activities within the financial services sector. The following text has been extracted from the Circular which contains a letter from Peter Cotgrove, the chairman of Merchant House : Introduction The intention of the board of the Company ('the Board') to change the Company's business strategy to that traditionally followed by a merchant bank was announced on 27th September 2002. The Board believes there is a real need for the provision of corporate finance and advisory services to the smaller corporate sector and that this presents significant opportunities consistent with the skills and experience of the Directors and executives of the Company. Since September 2002, a number of steps have been taken to facilitate the implementation of the proposed new strategy. Merchant Capital has been established as a wholly owned subsidiary and, on 9th May 2003, it received permission from the Financial Services Authority to carry on corporate finance and investment advisory business. The Board of the Company has been strengthened by the recruitment of a small team of new directors and executives experienced in corporate finance and related investment activities. The Directors have identified two areas within financial services where they consider particular opportunities to exist and which they consider are consistent with their skills and experience. These are the provision of corporate finance and advisory services to small and growing companies and specialist investment products and services. The Directors consider that the first of these activities remains relatively poorly served by larger, more established institutions and that an opportunity therefore exists to provide a cost-effective and broadly-based range of corporate finance services both directly and in partnership with other organisations. Activities in this area will include, but may not be restricted to, advice and assistance in relation to private fund-raisings, public issues, flotations and reversals and mergers and acquisitions. In the second area, the Directors believe that a niche exists for the establishment and marketing of specialist investment products and they also propose to develop this activity both directly and with associates. In due course, they will also consider the development of other investment services, such as private client investment management, though they have no present plans in that respect. The Company may invest on a selective basis in corporate situations where the Directors believe they have a particular insight or where particular opportunities for capital gains are believed to exist. The Directors believe that they can in this way leverage the benefits to be obtained from the Company's corporate work for clients. These investments may include investments in turnaround situations and quoted shell companies; such investments will not be restricted to the Company's own area of activity but will be related to the activities of its corporate and investment clients and associates. The Company will not invest a significant proportion of its liquid assets in any such investments without seeking such Shareholder approval as may be required under the AIM Rules. New Share Option Scheme The Directors propose to create a New Share Option Scheme to provide appropriate incentives for present and future directors and executives of the Company. It is proposed to establish a scheme that will allow for the issue of Share Options amounting to 15 per cent. of the issued Ordinary Share capital of the Company and for the amount of available Share Options to be maintained (at the discretion of the Directors) at 15 per cent. following any increase in the issued Ordinary Share capital during the twelve months following the EGM. It is proposed to issue Share Options amounting to 9.75 per cent. of the issued share capital to the Executive Directors of the Company and further Share Options to other executives and Directors of the Company. A committee of the Directors will be established to determine the precise terms and distribution of the Share Options. The residual pool of Share Options will be set aside for further executive employees of the Company or further to incentivise existing non-director executives as and when deemed appropriate by the Directors. Increase in Share Capital and Disapplication of Pre-emption Rights The Directors propose to seek Shareholder approval for the increase of the authorised share capital to 16,000,000 Ordinary Shares by the creation of a further 8,000,000 Ordinary Shares each to rank pari passu in all respects with the existing Ordinary Shares. In order to provide greater flexibility in developing the Company, the Directors are therefore seeking the disapplication of pre-emption rights over 6,800,000 Ordinary Shares in the Company, which may be issued in due course for cash. Recommendation The Directors consider that the change of business strategy, the increase in Company's authorised share capital, the authority to allot shares under Section 80 of the Act, the disapplication of pre-emption rights and the New Share Option Scheme, are in the best interests of the Company and Shareholders as a whole and recommend that Shareholders vote in favour of the Resolutions as they intend so to do in respect of their 91,000 Ordinary Shares representing 1.34 per cent. of the issued ordinary share capital of the Company. In addition, Delphic and London & Boston have given irrevocable undertakings to vote in favour of the Resolutions in respect of 5,157,500 Ordinary Shares, representing approximately 75.85 per cent. of the issued ordinary share capital of the Company. In aggregate, the Company has therefore received irrevocable undertakings to vote in favour of the Resolutions in respect of 5,248,500 Ordinary Shares representing 77.19 per cent. of the issued ordinary share capital of the Company.' Further information regarding the proposals described above is set out in the Circular. An Extraordinary General Meeting to approve these proposals will be held at 11.00am on 29th September 2003 at the offices of Wallace & Partners, One Portland Place, London, W1B 1PN. Contacts: Merchant House 020 7332 2200 Peter Cotgrove, Chairman, Peter Redmond, Director Shore Capital 020 7408 4090 Alex Borrelli Jonathan Nelson Definitions used in this announcement bear the same meaning as those defined in the Circular. This information is provided by RNS The company news service from the London Stock Exchange END CIRDGGGLZKZGFZM
1 Year Molina Healthcare Chart |
1 Month Molina Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions